Biotech Pharmaceutical Co., Ltd.
Biotech Pharmaceutical Co., Ltd.
Explore linked clinical trials.8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JH013 Injection in Patients With Primary Sjögren's Syndrome | Primary Sjögren's Syndrome (pSS) | Not yet recruiting | Phase 1 | 2026-09-14 | NCT07818694 | |
| JH021 in Patients With Advanced Solid Tumors or EGFR-Mutant NSCLC | Advanced Solid Tumor | Not yet recruiting | Phase 1 | 2026-05-13 | NCT07582822 | |
| JY016 Injection in Patients With Advanced Solid Tumors Expressing EGFR | Solid Cancers | Not yet recruiting | Phase 1 / Phase 2 | 2026-04-06 | NCT07510841 | |
| A Phase Ia Single Ascending-Dose Study of Subcutaneous EB070 Injection in Healthy Volunteers | Health Adult Subjects | Not yet recruiting | Phase 1 | 2026-02-17 | NCT07413536 | |
| A Single-Arm Phase II Clinical Study of Docetaxel Combined With Nimotuzumab and Pucotenlimab as Second-Line and Beyond Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Not yet recruiting | Phase 2 | 2026-01-21 | NCT07354984 | |
| A Trial of Nimotuzumab and Pinkiller Efficacy and Pain in Advanced Head and Neck Squamous Cell Carcinoma | Head and Neck Neoplasms, Neoplasms by Site, head and neck cancer, neoplasm | Active, not recruiting | Phase 4 | 2025-03-17 | NCT06879691 | |
| A Phase I Clinical Trial of JH013 Injection | Healthy Subjects (HS) | Not yet recruiting | Phase 1 | 2024-10-09 | NCT06633055 | |
| A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Not yet recruiting | Phase 3 | 2024-03-27 | NCT06333821 |